tetradecanoylphorbol acetate has been researched along with Polycystic Ovary Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, HC; Hou, M; Huang, HF; Jiang, ZR; Lin, J; Liu, XM; Sheng, JZ; Wang, HH; Wu, YM; Wu, YT; Yang, Q; Zhou, CL | 1 |
Ben-Shlomo, I; Goldman, S; Shalev, E | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Polycystic Ovary Syndrome
Article | Year |
---|---|
Prenatal exposure to testosterone induces cardiac hypertrophy in adult female rats through enhanced PkcĪ“ expression in cardiac myocytes.
Topics: Acetophenones; Androgens; Animals; Animals, Newborn; Benzopyrans; Cardiomegaly; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Myocytes, Cardiac; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Protein Kinase C-delta; Rats; Receptors, Androgen; Signal Transduction; Testosterone; Tetradecanoylphorbol Acetate | 2019 |
Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP, and progesterone secretion in luteinized granulosa cells from normally ovulating women with polycystic ovary disease.
Topics: Adult; Blotting, Western; Colforsin; Cyclic AMP-Dependent Protein Kinases; Epidermal Growth Factor; Female; Granulosa Cells; Humans; Luteinization; Matrix Metalloproteinase 9; Polycystic Ovary Syndrome; Progesterone; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1 | 2003 |